Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_4
1
17%
Ph not_applicable
2
33%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

completed233%
recruiting117%
not_yet_recruiting117%
terminated233%

Recent Activity

1 active trials
Showing 5 of 6
not_yet_recruitingphase_4

Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer

NCT07483060
recruitingnot_applicable

Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

NCT06209099
terminatednot_applicable

Comparison Between Tailored Surgery Versus Total Mesorectal Excision in ycT2-3N0M0

NCT05164315
completedphase_3

Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer

NCT02127645
terminatedphase_2

Neo-Adjuvant FOLFOX for Rectal Carcinoma

NCT00832299
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07483060Phase 4

Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer

Not Yet Recruiting
NCT06209099Not Applicable

Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

Recruiting
NCT05164315Not Applicable

Comparison Between Tailored Surgery Versus Total Mesorectal Excision in ycT2-3N0M0

Terminated
NCT02127645Phase 3

Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer

Completed
NCT00832299Phase 2

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Terminated
NCT00909987Phase 2

Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6